Literature DB >> 8150960

Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR.

T Yamamoto1, T Mukai, K Kondo, K Yamanishi.   

Abstract

The complete nucleotide sequence of one of the immediate-early genes of human herpesvirus 6 variant B was determined and compared with that of variant A reported by Martin et al. (M.D. Martin, J. Nicholas, B. J. Thomson, C. Newman, and R. W. Honess, J. Virol. 65:5381-5390, 1991). While it was reported that two open reading frames exist in this region of variant A, only one open reading frame was found in variant B and the putative coding region of variant B was 2,679 nucleotides long. Furthermore, two additive regions of 108 and 228 bp were found in variant B. Primers covering one of these regions deleted in variant A were synthesized and used for PCR amplification. Twelve isolates from patients were clearly classified into variants A and B by PCR amplification with these primers. All isolates from patients with exanthem subitum were variant B.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150960      PMCID: PMC263057          DOI: 10.1128/jcm.32.2.473-476.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

2.  DNA homology between a novel human herpesvirus (HHV-6) and human cytomegalovirus.

Authors:  S Efstathiou; U A Gompels; M A Craxton; R W Honess; K Ward
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

3.  Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2.

Authors:  H Agut; D Guetard; H Collandre; C Dauguet; L Montagnier; J M Miclea; H Baurmann; A Gessain
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321

4.  A novel lymphotropic herpesvirus.

Authors:  R S Tedder; M Briggs; C H Cameron; R Honess; D Robertson; H Whittle
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

5.  Isolation of human lymphotropic herpesviruses from Uganda.

Authors:  R G Downing; N Sewankambo; D Serwadda; R Honess; D Crawford; R Jarrett; B E Griffin
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

6.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

7.  Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates.

Authors:  D V Ablashi; N Balachandran; S F Josephs; C L Hung; G R Krueger; B Kramarsky; S Z Salahuddin; R C Gallo
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

10.  U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.

Authors:  T Dambaugh; K Hennessy; L Chamnankit; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more
  20 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Viral gene expression patterns in human herpesvirus 6B-infected T cells.

Authors:  Bodil Øster; Per Höllsberg
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 3.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Frequent detection of the human herpesvirus 6-specific genomes in the livers of children with various liver diseases.

Authors:  Y Ozaki; H Tajiri; K Tanaka-Taya; S Mushiake; A Kimoto; K Yamanishi; S Okada
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Human herpesvirus 6 open reading frame U83 encodes a functional chemokine.

Authors:  P Zou; Y Isegawa; K Nakano; M Haque; Y Horiguchi; K Yamanishi
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.

Authors:  H Asada; V Klaus-Kovtun; H Golding; S I Katz; A Blauvelt
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Coinfection with human herpesvirus 6 variants A and B in lung tissue.

Authors:  R W Cone; M L Huang; R C Hackman; L Corey
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor.

Authors:  Y Isegawa; Z Ping; K Nakano; N Sugimoto; K Yamanishi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 9.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

10.  The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential.

Authors:  W M Yeo; Yuji Isegawa; Vincent T K Chow
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.